Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer based in Kfar Saba, Israel, for the month of August 2016. The filing date is August 17, 2016. The report serves to notify the SEC of a corporate governance event rather than providing financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
The primary material event disclosed is the summoning of a Special General Meeting. This filing supersedes a previously furnished Exhibit 99.1 dated August 11, 2016, regarding the same meeting. No financial material changes are reported in this specific document.
Guidance, Outlook, and Risks
The filing includes an Immediate Report on Summoning a Special General Meeting (Exhibit 99.1) and a Voting Instruction Form (Exhibit 99.2). There is no management commentary on financial outlook, risks, contingencies, or unusual items within the text of this cover report.
Investor Verification Checklist
- Verify the agenda and specific resolutions to be voted on at the Special General Meeting referenced in Exhibit 99.1.
- Confirm the record date and meeting date for the Special General Meeting.
- Review the Voting Instruction Form (Exhibit 99.2) for shareholder action requirements.
- Note that this filing supersedes the August 11, 2016, report on the same subject.